Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026)
Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 10.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.95% |
| Dec 31, 2025 | -12.51% |
| Sep 30, 2025 | -30.53% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 15.68% |
| Dec 31, 2024 | -3.08% |
| Sep 30, 2024 | 17.75% |
| Jun 30, 2024 | 66.31% |
| Mar 31, 2024 | 503.04% |
| Dec 31, 2023 | 34.30% |
| Sep 30, 2023 | 65.06% |
| Jun 30, 2023 | 72.03% |
| Mar 31, 2023 | -23.71% |
| Dec 31, 2022 | -1.99% |
| Sep 30, 2022 | 54.13% |
| Jun 30, 2022 | 47.90% |
| Mar 31, 2022 | -58.23% |
| Dec 31, 2021 | 32.77% |
| Sep 30, 2021 | 143.05% |
| Jun 30, 2021 | -240.46% |